Barely Significant
← all excerpts

EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.

J Immunother Cancer · 2024 · PMC11459298 · PMID 39379098

Europe PMCDOI
1
hedged sentence
0.0400
closest p · 0.8× alpha
0.0400
boldest claim

The sentences

showed a trendp=0.04actually significant
The US cohort showed a trend towards less pronounced CRS events (p=0.04).

also in 25,348 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.